Suchergebnisse - "De Jong, Dirk"

PubPharm (16)

1

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients : A Nationwide Dutch Registry Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Straatmijer, T. | Biemans, V. | Visschedijk, M. | +52

CommentIn: Clin Gastroenterol Hepatol. 2023 May;21(5):1372-1373. - PMID 35850410

2

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Biemans, V. | van der Woude, C. | Dijkstra, G. | +14

CommentIn: Aliment Pharmacol Ther. 2020 Aug;52(4):753-754. - PMID 32886363

3

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease

enthalten in: World journal of gastroenterology | 2017

von Spekhorst, L. | Oldenburg, B. | van Bodegraven, A. | +11

4

Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease

enthalten in: Digestive diseases and sciences | 2017

von Smits, L. | Grelack, A. | Derikx, L. | +5

CommentIn: Dig Dis Sci. 2017 Nov;62(11):2964-2965. - PMID 28776140

5

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2017

von Wong, D. | Coenen, M. | Vermeulen, S. | +11

6

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

enthalten in: PloS one | 2016

von van der Valk, M. | Mangen, M. | Severs, M. | +19

7

Epstein-Barr virus in inflammatory bowel disease : the spectrum of intestinal lymphoproliferative disorders

enthalten in: Journal of Crohn's & colitis | 2015

von Nissen, L. | Nagtegaal, I. | de Jong, D. | +5

8

LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease

enthalten in: PloS one | 2015

von Broekman, M. | Roelofs, H. | Hoentjen, F. | +5

9

Elective switching from infliximab to adalimumab in stable Crohn's disease

enthalten in: Inflammatory bowel diseases | 2013

von Hoentjen, F. | Haarhuis, B. | Drenth, J. | +1

10

Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease

enthalten in: PloS one | 2009

von de Vries, H. | Plantinga, T. | van Krieken, J. | +9